Where every medicine has purpose, every person has potential, and every breakthrough is personal

At Kyowa Kirin, we are a Japanese based biopharmaceutical company that really focuses in rare disease. One of the things that makes Kyowa Kirin very unique is that we're not a large mega pharma. We are basically just the right size. We can be innovative like a biotech company, but at the same time, we have the resources of a large pharmaceutical company that frees us up to actually develop our innovation and get it to patients.

We are committed to life changing value. In other words, the products that we bring to market are not me to products, but they're products where there's real unmet need and where we feel we can make a real clinical difference in patients’ lives. We are completely committed to helping shorten the diagnostic journey for rare disease patients, as well as helping to make sure that once they are diagnosed, they can have easy access to our treatments.

One of the things that's really unique about us is what we call WA, which is bringing the team together to really break down barriers. We do that because we take the best of the Japanese culture and the best of the American culture. So we're innovative and we're driven, yet we really value teamwork and we really value that spirit of coming together and community.

I would also say that the products that we have in the market not only deliver life changing value, but are also relatively young in their life cycle. And when we look at our external and internal innovation, what that means is in Kyowa Kirin and at Kyowa Kirin, the future is ours to write. And I think that makes a very, very unique offering at Kyowa Kirin, and I look forward to you finding more about it.